Overview of IBA's Share Buyback Program
In a significant move to reinforce its commitment to shareholders, Ion Beam Applications SA (IBA) has successfully completed its share buyback program. This program, initiated earlier, aimed to repurchase up to 650,000 ordinary shares to support IBA's long-term incentive plans for its management and selected personnel.
Details of the Buyback Program
The buyback program officially commenced shortly after being announced. IBA took proactive steps by engaging a financial intermediary to manage the share repurchase process starting on March 25, 2025 and continuing until the end of the year. This careful planning ensures that the company effectively meets its obligations while optimizing shareholder value.
Execution of the Buyback
During the execution period, IBA purchased a total of 16,651 shares over two days, namely May 27 and 28, 2025. On May 27, they acquired 9,000 shares at an average price of €12.15, while on the following day, they bought 7,651 shares at an average price of €12.24. The strategically timed purchases highlight the company’s dedication to managing its capital efficiently.
Summary of Transactions
Here is a summarized look at the shares purchased:
Total Shares Purchased: 16,651
Average Price: €12.19
Total Expenditure: €203,014.21
Post Buyback Insights
With the conclusion of the buyback program, the total number of IBA shares purchased reached the authorized limit of 650,000. This development significantly influences IBA's treasury shares management. As of the latest reports, IBA directly and indirectly, through its subsidiary IBA Investments SRL, holds a combined total of 1,015,552 treasury shares, accounting for approximately 3.35% of the issued shares.
Treasury Shares Breakdown
The breakdown of treasury shares shows:
- IBA Investments SRL: 51,973 shares with 103,946 voting rights.
- IBA SA: 963,579 shares with 1,030,002 voting rights.
About Ion Beam Applications (IBA)
Founded in Belgium, IBA is a pioneer in the field of particle accelerator technology, leading the market in proton therapy equipment and services, renowned as the most advanced radiation therapy available today. The company also excels in sectors like industrial sterilization, radiopharmaceuticals, and dosimetry.
With a global presence, IBA employs around 2,100 individuals and is proud to be recognized as a certified B Corporation (B Corp), ensuring adherence to rigorous standards of verified social and environmental performance.
Company Profiles and Stock Information
Investors can follow Ion Beam Applications on the pan-European stock exchange EURONEXT under the ticker IBA (Reuters IBAB.BR and Bloomberg IBAB.BB). The recent steps taken by IBA to bolster its share value reflect positively on its long-term outlook.
Contact Information
IBA
Thomas Pevenage
Investor Relations
investorrelations@iba-group.com
Frequently Asked Questions
1. What was the purpose of IBA's share buyback program?
The buyback program aimed to acquire shares to fulfill the company's obligations under its long-term incentive plans for management and select personnel.
2. How many shares were repurchased by IBA?
IBA repurchased a total of 16,651 shares as part of this program before reaching the 650,000 share limit.
3. What is the average purchase price of the shares bought back?
The average purchase price of the shares during the buyback was €12.19.
4. How much did IBA spend in total on the buyback program?
IBA spent a total of €203,014.21 to complete the share buyback transactions.
5. How do treasury shares affect IBA's shareholder structure?
Treasury shares represent 3.35% of IBA's issued shares, indicating the company’s strategy to manage its capital effectively and potentially influence share value positively.
